Cited by 1,597Cancer Genomics and DiagnosticsGenomics and Rare DiseasesChromatin Remodeling and Cancer

The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.

The COSMIC Cancer Gene Census: describing genetic dysfunction across all human cancers

Open access

Sondka, Zbyslaw, Bamford, Sally, Cole, Charlotte G., Ward, Sari A., Dunham, Ian, Forbes, Simon A.·2018·Nature Reviews Cancer

DOI 10.1038/s41568-018-0060-1PMC PMC6450507

Open this paper in CoChat — free account

Abstract

The Catalogue of Somatic Mutations in Cancer (COSMIC) Cancer Gene Census (CGC) is an expert-curated description of the genes driving human cancer that is used as a standard in cancer genetics across basic research, medical reporting and pharmaceutical development. After a major expansion and complete re-evaluation, the 2018 CGC describes in detail the effect of 719 cancer-driving genes. The recent expansion includes functional and mechanistic descriptions of how each gene contributes to disease generation in terms of the key cancer hallmarks and the impact of mutations on gene and protein function. These functional characteristics depict the extraordinary complexity of cancer biology and suggest multiple cancer-related functions for many genes, which are often highly tissue-dependent or tumour stage-dependent. The 2018 CGC encompasses a second tier, describing an expanding list of genes (currently 145) from more recent cancer studies that show supportive but less detailed indications of a role in cancer.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/s41568-018-0060-1

Cites

102 of 102 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
The hallmarks of cancer
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Cancer Genome Landscapes
Vogelstein, B., Papadopoulos, N., Velculescu, V. E., Zhou, S., Diaz, L. A., & Kinzler, K. W. (2013) · Science · doi:10.1126/science.1235122 · Cited by 7,863
Mutation and cancer: statistical study of retinoblastoma
Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Dang, L., White, D. W., Gross, S., Bennett, B. D., Bittinger, M. A., Driggers, E. M., Fantin, V. R., Jang, H. G., Jin, S., Keenan, M. C., et al. (2009) · Nature · doi:10.1038/nature08617 · Cited by 4,154
A census of human cancer genes
Futreal, P. A., Coin, L., Marshall, M., Down, T., Hubbard, T., Wooster, R., Rahman, N., & Stratton, M. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1299 · Cited by 3,184
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
Flaherty, K. T., Puzanov, I., Kim, K. B., Ribas, A., McArthur, G. A., Sosman, J. A., O'Dwyer, P. J., Lee, R. J., Grippo, J. F., Nolop, K., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002011 · Cited by 3,103
Processing of primary microRNAs by the Microprocessor complex
Denli, A. M., Tops, B. B. J., Plasterk, R. H. A., Ketting, R. F., & Hannon, G. J. (2004) · Nature · doi:10.1038/nature03049 · Cited by 2,784
Wnt signaling in cancer
Zhan, T., Rindtorff, N., & Boutros, M. (2017) · Oncogene · doi:10.1038/onc.2016.304 · Cited by 2,626
The mutational landscape of lethal castration-resistant prostate cancer
Grasso, C. S., Wu, Y.-M., Robinson, D. R., Cao, X., Dhanasekaran, S. M., Khan, A. P., Quist, M. J., Jing, X., Lonigro, R. J., Brenner, J. C., et al. (2012) · Nature · doi:10.1038/nature11125 · Cited by 2,517

Show all 102 references

Sorted by citations

Items 701–800 of 998

Multi-omics-guided characterization of neoantigens improves patient stratification and potentiates combinatorial immunotherapy in glioma
Ma, Y., Cai, Y., Yang, J., Zhao, Z., Chen, Z., Lv, D., Yu, J., Yang, C., Liu, K., Zeng, M., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116704 · Cited by 8
The oncogenome of the domestic cat
Francis, B. A., Ludwig, L., He, C., Dobromylskyj, M., Bertram, C., Aupperle‐Lellbach, H., Wong, H. E., FOSTER, A. P., Arends, M. J., Suárez‐Bonnet, A., et al. (2026) · Science · doi:10.1126/science.ady6651 · Cited by 8
Genomic characterization of a newly established esophageal squamous cell carcinoma cell line from China and published esophageal squamous cell carcinoma cell lines
Li, X., Tian, D., Guo, Y. Z., Qiu, S., Xu, Z., Deng, W., & Su, M. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01268-x · Cited by 7
Next-generation sequencing revealed recurrent ZFPM1 mutations in encapsulated papillary carcinoma of the breast
Liu, X., Huang, X., Bai, Y., Zhang, Z., Jin, T., Wu, H., & Liang, Z. (2021) · npj Precision Oncology · doi:10.1038/s41698-021-00180-5 · Cited by 8
An integrative approach for exploring the nature of fibroepithelial neoplasms
Yun, J., Heo, W., Lee, E.-S., Na, D., Kang, W., Kang, J., Chae, J., Lee, D., Lee, W., Hwang, J., et al. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-02064-2 · Cited by 8
WGS Data Collections: How Do Genomic Databases Transform Medicine?
Król, Z. J., Dobosz, P., Ślubowska, A., & Mroczek, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24033031 · Cited by 8
An Integrative Analysis of Nasopharyngeal Carcinoma Genomes Unraveled Unique Processes Driving a Viral-Positive Cancer
Liu, X., Li, Y., Zhou, X., Zhu, S., Kaya, N. A., Chan, Y. S., Ma, L., Xu, M., & Zhai, W. (2023) · Cancers · doi:10.3390/cancers15041243 · Cited by 9
Association between hepatic angiosarcoma and end‐stage renal disease: nationwide population‐based evidence and enriched mutational signature of aristolochic acid exposure
Huang, S., Chang, I. Y., Chang, C., Liu, H., Chen, K., Liu, T., Hsieh, T.-Y., Chuang, H., Chen, C., Lin, I., et al. (2023) · The Journal of Pathology · doi:10.1002/path.6072 · Cited by 8
A drug repurposing approach for individualized cancer therapy based on transcriptome sequencing and virtual drug screening
Kadioglu, O., Bahramimehr, F., Dawood, M., Mahmoud, N., Elbadawi, M., Lu, X., Bülbül, Y., Schulz, J. A., Krämer, L., Urschel, M.-K., et al. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.106781 · Cited by 8
Functional characteristics of DNA N6-methyladenine modification based on long-read sequencing in pancreatic cancer
Zhou, D., Guo, S., Wang, Y., Zhao, J., Liu, H., Zhou, F., Huang, Y., Gu, Y., Jin, G., & Zhang, Y. (2023) · Briefings in Functional Genomics · doi:10.1093/bfgp/elad021 · Cited by 8
Concordance between whole exome sequencing of circulating tumor DNA and tumor tissue
Leenanitikul, J., Chanchaem, P., Mankhong, S., Denariyakoon, S., Fongchaiya, V., Arayataweegool, A., Angspatt, P., Wongchanapai, P., Prapanpoj, V., Chatamra, K., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0292879 · Cited by 8
Oncogene-Driven Non–Small Cell Lung Cancers in Patients with a History of Smoking Lack Smoking-Induced Mutations
Huang, C., Jiang, N., Shen, M., Lai, G. G. Y., Tan, A. C., Jain, A., Saw, S. P. L., Ang, M., Ng, Q. S., Lim, W., et al. (2024) · Cancer Research · doi:10.1158/0008-5472.can-23-2551 · Cited by 8
In silico RNA isoform screening to identify potential cancer driver exons with therapeutic applications
Anglada-Girotto, M., Ciampi, L., Bonnal, S., Head, S. A., Miravet-Verde, S., & Serrano, L. (2024) · Nature Communications · doi:10.1038/s41467-024-51380-z · Cited by 8
Identification of novel genetic loci related to dromedary camel (Camelus dromedarius) morphometrics, biomechanics, and behavior by genome-wide association studies
Pastrana, C. I., González, F. J. N., Macrì, M., Martínez, A. M., Ciani, E., & Bermejo, J. V. D. (2024) · BMC Veterinary Research · doi:10.1186/s12917-024-04263-w · Cited by 8
TRIM28-dependent developmental heterogeneity determines cancer susceptibility through distinct epigenetic states
Panzeri, I., Fagnocchi, L., Apostle, S., Tompkins, M., Wolfrum, E., Madaj, Z., Hostetter, G. H., Liu, Y., Schaefer, K., Yang, C.-H., et al. (2025) · Nature Cancer · doi:10.1038/s43018-024-00900-3 · Cited by 8
Cancer, Mankind′s Challenge
Cui, Y. (2019) · Current Cancer Reports · doi:10.25082/ccr.2019.01.001 · Cited by 9
NGS in CML ‐ New standard diagnostic procedure?
Branford, S., & Shanmuganathan, N. (2019) · HemaSphere · doi:10.1097/hs9.0000000000000199 · Cited by 8
Cancer susceptibility of beta HPV49 E6 and E7 transgenic mice to 4-nitroquinoline 1-oxide treatment correlates with mutational signatures of tobacco exposure
Viarisio, D., Robitaille, A., Müller‐Decker, K., Flechtenmacher, C., Gissmann, L., & Tommasino, M. (2019) · Virology · doi:10.1016/j.virol.2019.09.010 · Cited by 9
Spathial: an R package for the evolutionary analysis of biological data
Gardini, E., Giorgi, F. M., Decherchi, S., & Cavalli, A. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btaa273 · Cited by 8
Multigene editing: current approaches and beyond
Peng, H., Zheng, Y., Zhao, Z., & Li, J. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa396 · Cited by 8
Transdifferentiation of mantle cell lymphoma into sarcoma with limited neuromuscular differentiation after conventional chemotherapy
Kawashima, I., Oishi, N., Kasai, K., Inoue, T., Hosokawa, E., Nakadate, A., Matsuura, M., Kumagai, T., Koshiishi, M., Yamamoto, T., et al. (2021) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-021-03148-9 · Cited by 8
CNVIntegrate: the first multi-ethnic database for identifying copy number variations associated with cancer
Chattopadhyay, A. S., Teoh, Z. H., Wu, C.-Y., Juang, J. J., Lai, L., Tsai, M., Wu, C.-H., Lu, T., & Chuang, E. Y.-Y. (2021) · Database · doi:10.1093/database/baab044 · Cited by 8
Differential whole-genome doubling and homologous recombination deficiencies across breast cancer subtypes from the Taiwanese population
Wu, C.-H., Hsieh, C.-S., Chang, Y.-C., Huang, C., Yeh, H., Hou, M., Chung, Y., Tu, S., Chang, K., Chattopadhyay, A. S., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-02597-x · Cited by 8
Widespread redundancy in -omics profiles of cancer mutation states
Crawford, J., Christensen, B. C., Chikina, M. D., & Greene, C. S. (2022) · Genome biology · doi:10.1186/s13059-022-02705-y · Cited by 8
Overview and clinical significance of multiple mutations in individual genes in hepatocellular carcinoma
Imamura, T., Okamura, Y., Ohshima, K., Uesaka, K., Sugiura, T., Ito, T., Yamamoto, Y., Ashida, R., Ohgi, K., Otsuka, S., et al. (2022) · BMC Cancer · doi:10.1186/s12885-022-10143-z · Cited by 8
Shared Cancer Dataset Analysis Identifies and Predicts the Quantitative Effects of Pan-Cancer Somatic Driver Variants
Landau, J., Tsaban, L., Yaacov, A., Cohen, G. B., & Rosenberg, S. (2022) · Cancer Research · doi:10.1158/0008-5472.can-22-1038 · Cited by 7
Model performance and interpretability of semi-supervised generative adversarial networks to predict oncogenic variants with unlabeled data
Ren, Z., Li, Q., Cao, K., Li, M. M., Zhou, Y., & Wang, K. (2023) · BMC Bioinformatics · doi:10.1186/s12859-023-05141-2 · Cited by 8
Minimum error calibration and normalization for genomic copy number analysis
Gao, B., & Baudis, M. (2020) · Genomics · doi:10.1016/j.ygeno.2020.05.008 · Cited by 6
A newly identified small molecular compound acts as a protein kinase inhibitor to suppress metastasis of colorectal cancer
Qi, L., Zhang, Y., Song, F., Han, Y., & Ding, Y. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.104625 · Cited by 8
Multi-Omic Data Improve Prediction of Personalized Tumor Suppressors and Oncogenes
Sudhakar, M., Rengaswamy, R., & Raman, K. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.854190 · Cited by 8
Recombination of repeat elements generates somatic complexity in human genomesPreprint
Pascarella, G., Hashimoto, K., Busch, A., Luginbühl, J., Parr, C., Hon, C.-C., Yip, W. H., Abe, K., Kratz, A., Bonetti, A., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.07.02.163816 · Cited by 8
Evaluation of the Efficacy and Safety of a Clinical Grade Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Patch: A Pre-Clinical StudyPreprint
Miyagawa, S., Kawamura, T., Ito, E., Takeda, M., Iseoka, H., Yokoyama, J., Harada, A., Mochizuki‐Oda, N., Imanishi-Ochi, Y., Li, J., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.07.438744 · Cited by 8
Frequent somatic gene conversion as a mechanism for loss of heterozygosity in tumor suppressor genesPreprint
Takahashi, K., & Innan, H. (2022) · Genome Research · doi:10.1101/gr.276617.122 · Cited by 8
Characterization of Mammary Tumors Arising from MMTV-PyVT Transgenic Mice
Liu, C., Huang, W., Cheng, S., Chen, M., Lin, C., Chang, & Chang, Y. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45060286 · Cited by 7
SNPeffect 5.0: large-scale structural phenotyping of protein coding variants extracted from next-generation sequencing data using AlphaFold models
Janssen, K., Duran‐Romaña, R., Bottu, G., Guharoy, M., Botzki, A., Rousseau, F., & Schymkowitz, J. W. H. (2023) · BMC Bioinformatics · doi:10.1186/s12859-023-05407-9 · Cited by 7
IMI-driver: Integrating multi-level gene networks and multi-omics for cancer driver gene identification
Shi, P., Han, J., Zhang, Y., Li, G., & Zhou, X. (2024) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1012389 · Cited by 7
SPIDER: constructing cell-type-specific protein–protein interaction networks
Kupershmidt, Y., Kasif, S., & Sharan, R. (2024) · Bioinformatics Advances · doi:10.1093/bioadv/vbae130 · Cited by 7
Leveraging cancer mutation data to inform the pathogenicity classification of germline missense variants
Haque, B., Cheerie, D., Pan, A. Y., Curtis, M., Nalpathamkalam, T., Nguyen, J., Salhab, C., Thiruvahindrapuram, B., Zhang, J., Couse, M., et al. (2025) · PLoS Genetics · doi:10.1371/journal.pgen.1011540 · Cited by 8
Utilization of primary tumor samples for cancer neoantigen discovery
Leko, V., Groh, E. M., Levi, S. T., Copeland, A. R., White, B. S., Gasmi, B., Li, Y., Hill, V. K., Gurusamy, D., Levin, N., et al. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2024-010993 · Cited by 7
Transcription‐Replication Conflicts: Unlocking New Frontiers in Cancer
Bayona‐Feliú, A., & Aguilera, A. (2025) · BioEssays · doi:10.1002/bies.70025 · Cited by 7
ctDNA detectability and representativeness in seven body liquids from patients with metastatic breast cancer
Richard, F., Maetens, M., Baelen, K. V., Borremans, K., Cauwenberge, J. V., Zels, G., Rousseau, E., Geukens, T., Schepper, M. D., Mahdami, A., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-65838-1 · Cited by 7
Structure, Dynamics, and Impact of Replication Stress–Induced Structural Variants in Hepatocellular Carcinoma
Bayard, Q., Cordier, P., Péneau, C., Imbeaud, S., Hirsch, T. Z., Renault, V., Nault, J., Blanc, J., Caldéraro, J., Desdouets, C., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-3665 · Cited by 7
The contribution of uncharted RNA sequences to tumor identity in lung adenocarcinoma
Wang, Y., Xue, H., Aglave, M., Lainé, A., Gallopin, M., & Gautheret, D. (2022) · NAR Cancer · doi:10.1093/narcan/zcac001 · Cited by 6
A novel VCP::TFE3 gene fusion resulting from t(X;9)(p11.23;p13.3) chromosome translocation in TFE3 rearranged renal cancer cell carcinoma
Auvray, M., Blons, H., Gimenez‐Roqueplo, A., Just, P., Laurent‐Puig, P., Méjean, A., Oudard, S. M., & Verkarre, V. (2023) · Genes Chromosomes and Cancer · doi:10.1002/gcc.23127 · Cited by 7
Characterizing the role of Phlda3 in the development of acute toxicity and malignant transformation of hematopoietic cells induced by total-body irradiation in mice
Hasapis, S., Caraballo, I., Sears, T. J., Brock, K. D., Cart, J. B., Moding, E. J., & Lee, C. (2023) · Scientific Reports · doi:10.1038/s41598-023-39678-2 · Cited by 7
Pan-Cancer Profiling of Intron Retention and Its Clinical Significance in Diagnosis and Prognosis
Huang, L., Zeng, X., Ma, H., Yang, Y., Akimoto, Y., Wei, G., & Ni, T. (2023) · Cancers · doi:10.3390/cancers15235689 · Cited by 7
Reconstructing Disease Histories in Huge Discrete State Spaces
Schill, R., Klever, M., Rupp, K., Hu, Y. L., Lösch, A., Georg, P., Pfahler, S., Vocht, S., Hansch, S., Tilo Wettig, B., et al. (2024) · Künstliche Intell. · doi:10.1007/s13218-023-00822-9 · Cited by 7
Links between melanoma germline risk loci, driver genes and comorbidities: insight from a tissue‐specific multi‐omic analysis
Pudjihartono, M., Golovina, E., Fadason, T., O'Sullivan, J. M., & Schierding, W. S. (2024) · Molecular Oncology · doi:10.1002/1878-0261.13599 · Cited by 6
A drug recommendation system based on response prediction: Integrating gene expression and K-mer fragmentation of drug SMILES using LightGBM
Naveed, S., & Husnain, M. (2025) · Intelligence-Based Medicine · doi:10.1016/j.ibmed.2025.100206 · Cited by 7
Identification of breast cancer risk modules via an integrated strategy
Wan, L., Deng, G., Zhang, J., Hu, E., He, Y., Lv, J., Sun, X., Wang, K., & Chen, L. (2019) · Aging · doi:10.18632/aging.102546 · Cited by 7
Whole Genome Sequencing of Spontaneously Occurring Rat Natural Killer Large Granular Lymphocyte Leukemia Identifies JAK1 Somatic Activating Mutation
Wang, T. T., Yang, J., Dighe, S. A., Schmachtenberg, M. W., Leigh, N. T., Farber, E., Önengüt-Gümüşcü, S., Feith, D. J., Ratan, A., Loughran, T. P., et al. (2020) · Cancers · doi:10.3390/cancers12010126 · Cited by 7
Genomic landscape of a mouse model of diffuse-type gastric adenocarcinoma
Zhang, M., Sugita, I., Komura, D., Katoh, H., Shimada, S., Inazawa, J., Tanaka, S., & Ishikawa, S. (2021) · Gastric Cancer · doi:10.1007/s10120-021-01226-0 · Cited by 6
Assessment of Clonal Expansion Using CarcSeq Measurement of Lung Cancer Driver Mutations and Correlation With Mouse Strain- and Sex-Related Incidence of Spontaneous Lung Neoplasia
Harris, K. L., McKim, K. L., Myers, M. B., Gong, B., Xu, J., & Parsons, B. L. (2021) · Toxicological Sciences · doi:10.1093/toxsci/kfab098 · Cited by 7
Multiplex Gene Quantification as Digital Cancer Markers for Extremely Rapid Evaluation of Chemodrug Sensitivity
Fan, J., Feng, Y., Cheng, Y., Wang, Z., Zhao, H., Galan, E. A., Liao, Q., Cui, S., Zhang, W., & Ma, S. (2021) · Patterns · doi:10.1016/j.patter.2021.100360 · Cited by 7
Computational methods and translational applications for targeted next‐generation sequencing platforms
Luthra, A., Mastrogiacomo, B., Smith, S. A., Chakravarty, D., Schultz, N. D., & Sánchez-Vega, F. (2022) · Genes Chromosomes and Cancer · doi:10.1002/gcc.23023 · Cited by 7
Evaluating the predictive accuracy of curated biological pathways in a public knowledgebase
Wright, A. J., Orlic-Milacic, M., Rothfels, K., Weiser, J., Trinh, Q. M., Jassal, B., Haw, R., & Stein, L. D. (2022) · Database · doi:10.1093/database/baac009 · Cited by 7
Germline Variants in Cancer Genes from Young Breast Cancer Mexican Patients
Gómez‐Flores‐Ramos, L., Barraza-Arellano, A. L., Mohar, A., Trujillo-Martínez, M., Grimaldo, L., Ortı́z-López, R., & Treviño, V. (2022) · Cancers · doi:10.3390/cancers14071647 · Cited by 7
Genomic profile of radiation-induced early-onset mouse B-cell lymphoma recapitulates features of Philadelphia chromosome-like acute lymphoblastic leukemia in humans
Tachibana, H., Daino, K., Ishikawa, A., Morioka, T., Shang, Y., Ogawa, M., Matsuura, A., Shimada, Y., & Kakinuma, S. (2022) · Carcinogenesis · doi:10.1093/carcin/bgac034 · Cited by 7
Comprehensive patient-level classification and quantification of driver events in TCGA PanCanAtlas cohorts
Vyatkin, A. D., Otnyukov, D. V., Leonov, S. V., & Belikov, A. V. (2022) · PLoS Genetics · doi:10.1371/journal.pgen.1009996 · Cited by 7
Integration of Protein-Protein Interaction Networks and Gene Expression Profiles Helps Detect Pancreatic Adenocarcinoma Candidate Genes
Su, L., Liu, G., Guo, Y., Zhang, X., Zhu, X., & Wang, J. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.854661 · Cited by 7
Mapping the cell-membrane proteome of the SKBR3/HER2+ cell line to the cancer hallmarks
Lazar, I. M., Karcini, A., & Haueis, J. R. S. (2022) · PLoS ONE · doi:10.1371/journal.pone.0272384 · Cited by 7
Multi-omics analysis unravels the underlying mechanisms of poor prognosis and differential therapeutic responses of solid predominant lung adenocarcinoma
Li, F., Wang, S., Wang, Y., Lv, Z., Jin, D., Yi, H., Fu, L., Zhai, S., Xiao, T., & Mao, Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1101649 · Cited by 7
Somatic ARAF mutations in pediatric Langerhans cell histiocytosis: clinicopathologic, genetic and functional profiling
Liu, R., Guo, Y., Han, L., Feng, S., Cao, J., Sun, Y., Cao, Z., & Cui, X. (2023) · Clinical and Experimental Medicine · doi:10.1007/s10238-023-01134-w · Cited by 7
Sequence dependencies and mutation rates of localized mutational processes in cancer
Poulsgaard, G. A., Sørensen, S. G., Juul, R. I., Nielsen, M. M., & Pedersen, J. S. (2023) · Genome Medicine · doi:10.1186/s13073-023-01217-z · Cited by 8
Mutational signature and prognosis in adenocarcinoma of the bladder
Yang, G., Shahatiaili, A., Bai, S., Wang, L., Jin, D., Cao, M., Su, P., Liu, Q., Tao, K., Long, Q., et al. (2024) · The Journal of Pathology · doi:10.1002/path.6239 · Cited by 7
Detecting and understanding meaningful cancerous mutations based on computational models of mRNA splicing
Lynn, N., & Tuller, T. (2024) · npj Systems Biology and Applications · doi:10.1038/s41540-024-00351-7 · Cited by 5
Extend the benchmarking indel set by manual review using the individual cell line sequencing data from the Sequencing Quality Control 2 (SEQC2) project
Gong, B., Li, D., Zhang, Y., Kusko, R. L., Lababidi, S., Cao, Z., Chen, M., Chen, N., Chen, Q., Chen, Q., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-57439-7 · Cited by 7
MaveQuest: a web resource for planning experimental tests of human variant effects
Kuang, D., Weile, J., Li, R., Ouellette, T. W., Barber, J. A., & Roth, F. P. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btaa228 · Cited by 7
DriveWays: a method for identifying possibly overlapping driver pathways in cancer
Baali, I., Erten, C., & Kazan, H. (2020) · Scientific Reports · doi:10.1038/s41598-020-78852-8 · Cited by 7
Weighted minimum feedback vertex sets and implementation in human cancer genes detection
Li, R., Lin, C., Guo, W.-F., & Akutsu, T. (2021) · BMC Bioinformatics · doi:10.1186/s12859-021-04062-2 · Cited by 7
Assessing consistency across functional screening datasets in cancer cells
Cai, L., Liu, H., Minna, J. D., DeBerardinis, R. J., Xiao, G., & Xie, Y. (2021) · Bioinformatics · doi:10.1093/bioinformatics/btab423 · Cited by 6
DAGM: A novel modelling framework to assess the risk of HER2-negative breast cancer based on germline rare coding mutations
Yang, M., Fan, Y., Wu, Z., Gu, J., Feng, Z., Zhang, Q., Han, S., Zhang, Z., Li, X., Hsueh, Y.-C., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103446 · Cited by 7
Systematic identification of novel cancer genes through analysis of deep shRNA perturbation screens
Montazeri, H., Coto‐Llerena, M., Bianco, G., Zangene, E., Taha‐Mehlitz, S., Paradiso, V., Srivatsa, S., de Weck, A., Roma, G., Lanzafame, M., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab627 · Cited by 7
De novo individualized disease modules reveal the synthetic penetrance of genes and inform personalized treatment regimensPreprint
Weisskittel, T., Ung, C. Y., Correia, C., Zhang, C., & Li, H. (2021) · Genome Research · doi:10.1101/gr.275889.121 · Cited by 7
Identification of germline population variants misclassified as cancer-associated somatic variants
Pollard, R. D., Wilkerson, M. D., & Rajagopal, P. S. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1361317 · Cited by 6
Genomic and Transcriptomic Analysis of Ameloblastoma Reveals Distinct Molecularly Aggressive Phenotypes
Marín, C. C. N., Adisa, A. O., Niklander, S. E., Kirby, J., & Hunter, K. D. (2024) · Modern Pathology · doi:10.1016/j.modpat.2024.100682 · Cited by 6
In Vivo CRISPR Activation Screening Reveals Chromosome 1q Genes VPS72, GBA1, and MRPL9 Drive Hepatocellular Carcinoma
Vázquez-Salgado, A. M., Cai, C., Lee, M., Yin, D., Chrystostome, M.-L., Gefre, A. F., He, S., Kieckhaefer, J. E., & Wangensteen, K. J. (2025) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2025.101460 · Cited by 6
Genomic characteristics and prognostic correlations in Chinese multiple myeloma patients
Chen, X., Luo, T., Zhang, W., Wang, S., Zhu, M., He, H., Liu, J., Lü, J., Qiang, W., Jia, Y., et al. (2025) · BMC Medical Genomics · doi:10.1186/s12920-025-02116-5 · Cited by 6
MYC deregulation sensitizes cancer cells to N-myristoyltransferase inhibition.
Lueg, G. A., Zhang, J., Faronato, M., Gorelik, A., Kallemeijn, W. W., Falciani, F., Walton, J., Houghton, J. W., Vannini, S., Poon, E., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116180 · Cited by 7
Plasma exosomes from individuals with type 2 diabetes drive breast cancer aggression in patient-derived organoids
Ennis, C. S., Seen, M., Chen, A., Kang, H., Ilinski, A., Mahdaviani, K., Ko, N. Y., Monti, S., & Denis, G. V. (2025) · Communications Biology · doi:10.1038/s42003-025-08663-y · Cited by 7
Association for Clinical Genomic Science (ACGS) guidelines for the classification of oncogenicity of somatic variants in cancer: recommendations by the UK somatic variant interpretation group (SVIG-UK)
Burghel, G. J., Mason, J., Baker, K., Moloney, K., McKeeve, C., Cartwright, A., Brás-Goldberg, A. M., Travis, D., Lewis, S., Fairley, J. A., et al. (2025) · Journal of Medical Genetics · doi:10.1136/jmg-2025-111046 · Cited by 7
Identification of Biomarkers for Osteosarcoma Based on Integration Strategy
Bao, J., Song, Z., Song, C., Wang, Y., Wan, L., Mai, W., Shi, Q., Yu, H., Ni, L., Liu, Y., et al. (2020) · Medical Science Monitor · doi:10.12659/msm.920803 · Cited by 6
Dr.Nod: computational framework for discovery of regulatory non-coding drivers in tissue-matched distal regulatory elements
Tomková, M., Tomek, J., Chow, J. C., McPherson, J. D., Segal, D. J., & Hormozdiari, F. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac1251 · Cited by 6
Discovering cryptic splice mutations in cancers via a deep neural network framework
Teboul, R., Grabias, M., Zucman‐Rossi, J., & Letouzé, É. (2023) · NAR Cancer · doi:10.1093/narcan/zcad014 · Cited by 6
Multi-omics integration analysis unveils heterogeneity in breast cancer at the individual level
Zhao, Z., Jin, T., Chen, B., Dong, Q., Liu, M., Guo, J., Song, X., Li, Y., Chen, T., Han, H., et al. (2023) · Cell Cycle · doi:10.1080/15384101.2023.2281816 · Cited by 6
Transcriptome analysis of primary adult B ‐cell lineage acute lymphoblastic leukemia identifies pathogenic variants and gene fusions, and predicts subtypes for in depth molecular diagnosis
Podgorica, M., Drivet, E., Viken, J. K., Richman, A. R., Vestbøstad, J., Szodoray, P., Kvam, A. K., Wik, H. S., Tjønnfjord, G. E., Munthe, L. A., et al. (2024) · European Journal Of Haematology · doi:10.1111/ejh.14164 · Cited by 6
Large-Scale Alternative Polyadenylation-Wide Association Studies to Identify Putative Cancer Susceptibility Genes
Guo, X., Ping, J., Yang, Y., Su, X., Shu, X., Wen, W., Chen, Z., Zhang, Y., Tao, R., Jia, G., et al. (2024) · Cancer Research · doi:10.1158/0008-5472.can-24-0521 · Cited by 6
Identifying somatic driver mutations in cancer with a language model of the human genome
Zeng, G., Zhao, C., Li, G., Huang, Z., Zhuang, J., Liang, X., Yu, X., & Fang, S. (2025) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2025.01.011 · Cited by 6
Deciphering precursor cell dynamics in esophageal preneoplasia via genetic barcoding and single-cell transcriptomics
Jang, J., Ko, K.-P., Zhang, J., Jun, S., & Park, J. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2509534122 · Cited by 5
Correlation of Immunological and Molecular Profiles with Response to Crizotinib in Alveolar Soft Part Sarcoma: An Exploratory Study Related to the EORTC 90101 “CREATE” Trial
Lee, C., Modave, E., Boeckx, B., Kasper, B., Aamdal, S., Leahy, M. G., Rutkowski, P. L., Bauer, S., Dêbiec‐Rychter, M., Sciot, R., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105689 · Cited by 6
Modeling tissue-specific breakpoint proximity of structural variations from whole-genomes to identify cancer drivers
Martinez‐Fundichely, A., Dixon, A., & Khurana, E. (2022) · Nature Communications · doi:10.1038/s41467-022-32945-2 · Cited by 5
HNRNPA2B1 as a potential therapeutic target for thymic epithelial tumor recurrence: An integrative network analysis
Zhou, Z., Lu, Y., Gu, Z., Sun, Q., Fang, W., Yan, W., Ku, X., Liang, Z. T., & Hu, G. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.106665 · Cited by 6
Salivary gland cancer organoids are valid for preclinical genotype-oriented medical precision trials
Ishikawa, T., Ogawa, T., Shiihara, M., Usubuchi, H., Omori, Y., Hirose, K., Itoh, T., Yoshida, T., Nakanome, A., Ohkoshi, A., et al. (2023) · iScience · doi:10.1016/j.isci.2023.106695 · Cited by 6
ADP-Ribosylation Factor 6 Pathway Acts as a Key Executor of Mesenchymal Tumor Plasticity
Hashimoto, A., & Hashimoto, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914934 · Cited by 6
Whole exome sequencing uncovers HRAS mutations as potential mediators of resistance to metronomic chemotherapy
Sambath, J., Noronha, V., Manda, S. S., Mishra, R., Chandrani, P., Patil, V., Menon, N. S., Chougule, A., Venkataramanan, R., Limaye, S. A., et al. (2023) · Gene · doi:10.1016/j.gene.2023.147952 · Cited by 6
PRADclass: Hybrid Gleason Grade-Informed Computational Strategy Identifies Consensus Biomarker Features Predictive of Aggressive Prostate Adenocarcinoma
Balraj, A. S., Muthamilselvan, S., Raja, R., & Palaniappan, A. (2024) · Technology in Cancer Research & Treatment · doi:10.1177/15330338231222389 · Cited by 6
CSSLdb: Discovery of cancer-specific synthetic lethal interactions based on machine learning and statistic inference
Dou, Y., Ren, Y., Zhao, X., Jin, J., Xiong, S., Luo, L., Xu, X., Yang, X., Yu, J., Guo, L., et al. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.108066 · Cited by 6
A retrospective study on the mechanism underlying quick transfer from response to resistance in a repeated recurrent chordoma patient with molecular alterations treated with Palbociclib
Zhong, N., Dong, Y., Yang, M., Lu, X., Zhang, Q., Wei, W., Jiao, J., Yang, X., Zhu, Z., Chen, S., et al. (2024) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-05560-x · Cited by 6
Ductal carcinoma in situ develops within clonal fields of mutant cells in morphologically normal ducts
Hutten, S. J., Messal, H. A., Lips, E. H., Sheinman, M., Ciwinska, M., Braams, E., van der Borden, C., Kristel, P., Stoffers, S., Wessels, L. F. A., et al. (2024) · The Journal of Pathology · doi:10.1002/path.6289 · Cited by 6
Multidrug-Resistant Profiles in Non-Small Cell Lung Carcinoma Patient-Derived Cells: Implications for Personalized Approaches with Tyrosine Kinase Inhibitors
Dinić, J., Dragoj, M., Stojanov, S. J., Stepanović, A., Lupšić, E., Pajović, M., Mohr, T. T., Glumac, S., Marić, D., Ercegovac, M., et al. (2024) · Cancers · doi:10.3390/cancers16111984 · Cited by 6

Authors: Sondka, Z., Bamford, S., Cole, C. G., Ward, S. A., Dunham, I., & Forbes, S. A.
Affiliations: Wellcome Sanger Institute (GB)
European Bioinformatics Institute (GB)
ORCID: Dunham, Ian
Venue: Nature Reviews Cancer
Publisher: Springer Science and Business Media LLC
Published: 2018-10-06
Volume: 18
Issue: 11
Pages: 696-705
ISSN: 1474-175X (ISSN-L)
1474-1768
DOI: 10.1038/s41568-018-0060-1
PMC: PMC6450507
OpenAlex: W2894573839
Cited by: 1,597
References: 102
Citations by year: 2026: 125 · 2025: 227 · 2024: 242 · 2023: 239 · 2022: 260 · 2021: 250 · 2020: 167 · 2019: 75 · 2018: 8
FWCI: 13.23
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Nature reviews. Cancer (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: Wellcome Trust
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
Keywords: somatic mutations, cancer genetics, gene function, cancer hallmarks, expert curation, cancer genomics
MeSH terms: Humans, Mutation, Neoplasms, Censuses

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The COSMIC Cancer Gene Census: describing genetic dysfunction across all human cancers

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks